Arnold C. Hanish - Nov 25, 2019 Form 4/A - Amendment Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Director
Signature
/s/David Arthur, as Attorney-in-Fact
Stock symbol
SLRX
Transactions as of
Nov 25, 2019
Transactions value $
$10,770
Form type
4/A - Amendment
Date filed
6/6/2022, 08:27 PM
Date Of Original Report
Nov 26, 2019
Next filing
Jun 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Purchase $10.8K +3K $3.59 3K Nov 25, 2019 By Arnold C. Hanish Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to amend the Form 4 filed by the Reporting Person on November 26, 2019 to reflect that the securities reported are indirectly beneficially owned as indicated herein.